Full-Time

Research Assistant

Posted on 9/4/2026

Care Access

Care Access

501-1,000 employees

Global health education, access, and research

Compensation Overview

$65k - $75k/yr

+ 401(k) match + Bi-weekly HSA employer contribution

No H1B Sponsorship

Remote in USA

Remote

Remote within the United States with less than 10% occasional planned travel.

Category
Biology & Biotech (1)
Required Skills
Medical Terminology
Word/Pages/Docs
Excel/Numbers/Sheets
Microsoft Outlook

Get referred to Care Access

See people who can refer or advise you

Requirements
  • A minimum of 2 years of relevant clinical research experience.
  • Highly proficient use of clinical research technologies, including recruitment platforms, Interactive Web Response Systems, Electronic Data Capture, and other clinical trial software across multiple platforms.
  • Proficiency with Microsoft Office applications, including Word, Outlook, Teams, and Excel.
  • Professional conduct and effective work with diverse individuals.
  • Ability to recognize when issues require escalation.
  • Strong communication and customer service abilities.
  • Proficiency in research terminology and basic medical terminology.
  • Understanding of the clinical development paradigm and working knowledge of government regulations, Good Clinical Practice, and ALCOA-C.
  • Strong organization and time management skills.
  • High attention to detail.
  • Ability to work in a fast-paced environment and solve problems critically.
  • Ability to work effectively in a remote environment.
  • Proper home-office setup with a private space for participant communication and high-speed internet of at least 100 Mbps upload, 15 Mbps download, and a 5 GHz router.
Responsibilities
  • Identify, recruit, educate, and pre-screen potential patients for studies.
  • Analyze study protocols and associated diseases to educate patients and families about study participation.
  • Explain studies to patients in understandable language.
  • Interpret patient-reported medical history and medication use to determine pre-screening qualification.
  • Assess patient readiness for screening visits and coordinate further discussion with the study doctor when needed.
  • Review required study visits and protocol timelines to ensure scheduling within protocol windows.
  • Coordinate with the Central Study Coordinator to schedule all applicable protocol-mandated activities.
  • Contact patients to collect information, remind them about appointments, and support patient retention.
  • Verify study-visit completion through system checks and process patient stipend payments.
  • Communicate principal investigator decisions about study eligibility to patients.
  • Communicate with patients through phone, email, and video conference.
  • Document patient interactions according to Good Clinical Practice and ALCOA-C.
  • Troubleshoot technology issues for patients.
  • Maintain current information across multiple study portals.
  • Review data backlogs and prioritize data entry, cleanup, and query resolution according to study needs.
  • Enter data into the correct systems within required study and site time frames.
  • Attend scheduled meetings with principal investigators and site teams.
  • Review completed work and prepare site-meeting agendas.
  • Present progress information, escalations, and clarification items to the principal investigator alongside the Central Study Coordinator.
  • Communicate with study sites between scheduled calls to resolve issues and questions.
  • Identify potential imaging facilities for patients.
  • Explain imaging requirements to facilities according to the protocol.
  • Negotiate contracts with potential imaging facilities.
  • Act as liaison between imaging facilities and the central study imaging reader throughout the study.
  • Analyze and understand study protocols.
  • Support preparation of regulatory documents and obtain required signatures.
  • Troubleshoot technical issues.
  • Assist with study-related administrative activities.
  • Use keyboards and other computer equipment.
  • Travel occasionally as planned, with less than 10% travel.
Desired Qualifications
  • Spanish fluency.

Care Access coordinates global efforts to improve health by educating people about health, helping them access needed resources, and enabling participation in medical research to develop new medicines and cures. Its approach involves a global network and services that educate individuals, connect them with health resources, and recruit participants for clinical studies, thereby supporting the development of new treatments. Unlike companies that focus on a single market or product, Care Access operates worldwide and focuses on easing access to information, services, and research opportunities for diverse populations. The goal is to make health information and access more available and participation in health studies easier, with the aim of making the future of health better for everyone.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Boston, Massachusetts

Founded

2016

Get referred to Care Access

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Walmart opened first Care Access sites in Texas and Georgia on 2026-04-29.
  • Care Access reported 852 employees and 163 active 2026 job postings.
  • The company added Warsaw in 2024 and CEMEC in Brazil in 2025.

What critics are saying

  • Walmart locations in Houston, Tyler, and Dalton hinge on flawless spring 2026 execution.
  • Pfizer and Valneva blamed Care Access in 2023; sponsor trust remains fragile.
  • If a major sponsor exits after a compliance failure, the decentralized model collapses.

What makes Care Access unique

  • Care Access pairs community screenings with Phase 2-4 trials inside Walmart stores, 2026.
  • Its decentralized model uses mobile clinics, Sites On Demand, and local partnerships globally.
  • Brazil, Poland, and U.S. sites create a geographically distributed recruitment engine.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

-4%
8th & Walton
Apr 29th, 2026
Walmart brings clinical trials into the community - walmart.com.

Walmart brings clinical trials into the community - walmart.com. Walmart is bringing clinical research into everyday community spaces through the Walmart Healthcare Research Institute and a new Clinical Trial Center collaboration with Care Access. Key takeaways. * Research closer to home: The Clinical Trial Center by Walmart and Care Access is opening initial sites in Houston and Tyler, Texas, and Dalton, Georgia, placing trial locations inside familiar store environments. * Focus on underserved communities: Walmart Healthcare Research Institute was created to expand access to clinical trials and improve care for communities historically underrepresented in research. * New model for medical innovation: Care Access will run screenings and trials, while Walmart supports outreach, with leaders describing the effort as a new way to deliver clinical research.

SmartBrief
Jan 22nd, 2026
Walmart, Care Access to partner on clinical research

Walmart, Care Access to partner on clinical research. Walmart will partner with Care Access to launch a clinical research initiative this spring that will bring clinical trial opportunities to markets, including rural areas that often lack access to cutting-edge medical research. The retailer will open research sites at select stores and former Walmart Health clinic locations. By using familiar community spaces, Walmart hopes to make participation in clinical research more accessible and convenient for local residents. Designed specifically for retail professionals, NRF SmartBrief is a free, daily email newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition.

First Free Church Chicago
Dec 1st, 2024
Care Access Senior Fair | December 6 + 7

On December 6th and 7th Firstfree is partnering with Care Access, an organization with a mission to connect the community with equitable health research.

Business Wire
Mar 18th, 2024
Care Access Opens New Clinical Research Site In Warsaw, Poland

BOSTON--(BUSINESS WIRE)--Care Access, a global clinical research site company helping to accelerate the future of medicine, has opened its newest research site in Warsaw, Poland. The company’s expansion in Poland reinforces its commitment to improving access to clinical research globally through its innovative model of bringing clinical trials wherever they are needed. In recent years, Care Access has been active in clinical research across Europe, and now, by establishing a new facility in Warsaw, Care Access is further expanding its European services aimed to implement its industry-leading research capabilities, such as its Community Screening Program, Sites On Demand, and Mobile Research Site Infrastructure. These capabilities have shown to accelerate research study enrollment by adapting to the unique makeup of each community and providing more convenient ways to participate in clinical trials. “Poland plays an important role in bringing the future of medicine to reality,” said Rupi Bancil, Senior Vice President of Global Study Operations Expansion for Care Access. “The Warsaw site will improve access to advanced health screenings and research opportunities to communities throughout Poland.”

Business Wire
Mar 4th, 2024
New Study Addressing Global Concern For Breast Cancer Treatment Now Available In Clifton, N.J.

BOSTON--(BUSINESS WIRE)--A cancer research study focusing on hormone receptor-positive HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) is now available to patients in the Clifton, N.J., area. The SERENA-6 trial, sponsored by AstraZeneca, is a global study that aims to address a critical issue faced by many patients: their treatments become less effective over time. In advanced breast cancer, patients receive a treatment that combines an estrogen-reducing drug with a drug that slows cancer cell growth. While this combination works well, over time, it may stop working because of mutations in the ESR1 gene. This study will evaluate if an experimental trial drug, combined with a cancer-slowing drug, might work better than conventional estrogen-reducing drugs for patients with ESR1 mutations